首页> 外国专利> The use of a compound or a pharmacologically acceptable salt or solvato, or a pharmacologically functional derivative, compound or a pharmacologically acceptable salt or solvato, or a functional derivative of the same, pharmaceutical formulation, the combination product, and methods for inib scanning Idores cell proliferation induced by free fatty acid.And for CO stimulators of cell proliferation induced by free fatty acid.

The use of a compound or a pharmacologically acceptable salt or solvato, or a pharmacologically functional derivative, compound or a pharmacologically acceptable salt or solvato, or a functional derivative of the same, pharmaceutical formulation, the combination product, and methods for inib scanning Idores cell proliferation induced by free fatty acid.And for CO stimulators of cell proliferation induced by free fatty acid.

机译：化合物或药理学上可接受的盐或溶剂化物或药理学上的功能性衍生物，化合物或药理学上可接受的盐或溶剂化物或它们的功能性衍生物的用途，药物制剂，组合产品以及用于Inib扫描Idores细胞的方法由游离脂肪酸诱导的细胞增殖。以及用于CO刺激的由游离脂肪酸诱导的细胞增殖。

页面导航

摘要
著录项
相似文献

摘要

The use of a compound or a pharmacologically acceptable salt or sun vato, or a derivative, pharmacologically functional compound or a salt thereof, or a pharmacologically acceptable solvato, or a functional derivative of the same, pharmaceutical formulation, the combination product, and methods for inhibiting scanning The pain of cell proliferation induced by free fatty acid.And for CO stimulators of cell proliferation induced by fatty acid limre is equipped with a use of a compound of formula (1), in which X, y, Y5, W ~ 1 ~ ~ 2 ~ R ~ 1 ~ R ~ 5 ~ R ~ 6 ~ have the meanings data in the description, for the manufacture of a medicament for the treatment of a disorder Oucondiu00e7u00e3o caused by, associated with, or which contributes to the free fatty acids.Such that the hiperinsulinemia and associated conditions, including type 2 diabetes and the like.

机译：化合物或其药理学上可接受的盐或防晒剂，或其衍生物，药理学上可接受的化合物或其盐，或其药理学上可接受的溶剂化物或它们的功能性衍生物的用途，药物制剂，组合产品和方法抑制扫描是由游离脂肪酸引起的细胞增殖的痛苦。对于由脂肪酸CO诱导的CO刺激细胞增殖所配备的通式（1）的化合物，其中X，y，Y5，W〜1 〜〜2〜R〜1〜R〜5〜R〜6〜具有说明书中的含义数据，用于制造用于治疗Oucondi u00e7 u00e3o疾病的药物，该疾病是由，与之相关或贡献的从而导致胰岛素抵抗和相关疾病，包括2型糖尿病等。

著录项

公开/公告号BRPI0613624A2

专利类型
公开/公告日2011-01-18

原文格式PDF
申请/专利权人 BETAGENON AB;
展开▼

申请/专利号BR2006PI13624
发明设计人 BJOERN ERIKSSON;CHRISTIAN HEDBERG;JACOB WESTMAN;GUIDO KURZ;
展开▼

申请日2006-07-21
分类号A61K31/426;A61K31/421;A61P3/10;A61P13/12;A61P25/28;
国家 BR
入库时间 2022-08-21 18:07:16

相似文献

专利
外文文献